| News

Basel is evolving into a pediatrics hub

18.12.2019

The Botnar Research Center for Child Health in Basel has started its research activities. The first four projects have now been selected. Together with the DayOne Accelerator from BaselArea.swiss, Basel is gradually evolving into a pediatrics hub.

Children should benefit from research in Basel (img: Creative Commons)

The Botnar Research Center for Child Health (BRCCH) aims to foster novel and innovative research in pediatrics, a field in which the center benefits from partnerships with the University of Basel, the University Children’s Hospital Basel, the Swiss Tropical and Public Health Institute (Swiss TPH) and the Federal Institute of Technology in Zurich (ETH), according to a statement. On January 30, 2020, the BRCCH is hosting its first Spotlight Day in Basel, where it will showcase the four research projects that are kickstarting the center’s activities.

One project features an app with a digital medical system that can support the wellbeing of infants and young children growing up in rural areas of low-and middle-income countries. The platform is being assessed via a study of 2,400 children in Peru. Children with cleft lip or palate are the focus of the second project, which seeks to optimize surgical treatment with the use of artificial intelligence, smartphone-based images and 3D-printing of orthopedic plates.

For the third project, researchers are examining gut floral to fight infection and inflammatory disease in children. Using a CRISPR-based technology, they aim to develop bacteria that will provide assessments of the gut to improve the health of affected children. Gut bacteria are also the focus of the fourth project, which plans to replace “bad” bacteria with useful bacteria. This modification will be achieved with the help of engineered antibodies, and the direct targeting of individual genes in intestine-resident bacteria by employing CRISPR-Cas9 methodology.

The research activities at the BRCCH cement Basel’s growing reputation as a pediatrics hub. The city’s location promotion organization BaselArea.swiss is also using its DayOne Accelerator to support Digital Health startups that are working to improve the health of children and young people. Participants for the second round were recently announced.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

VectivBio secures investments totaling 110 million dollars
Basel Area Business & Innovation, Innovation, Invest

VectivBio secures investments totaling 110 million dollars

The Basel-based biotechnology firm VectivBio has received a capital injection of 110 million US dollars from both new and existing...

Read More
Polyphor receives up to 18 million dollars for development of antibiotics
Basel Area Business & Innovation, Innovation, Invest

Polyphor receives up to 18 million dollars for development of antibiotics

The Allschwil-based company Polyphor has received a second funding award from the global consortium CARB-X to combat antimicrobial resistance. Polyphor...

Read More
What makes Switzerland’s economy resilient in face of COVID pandemic
Basel Area Business & Innovation, Invest

What makes Switzerland’s economy resilient in face of COVID pandemic

The COVID-19 pandemic has hit economies worldwide – and we have not yet overcome it. However, Switzerland is among the...

Read More
DayOne Accelerator applications open
Basel Area Business & Innovation, Innovation

DayOne Accelerator applications open

We are excited to announce the opening of the call for the DayOne Accelerator, now in its 3rd year!

Read More
Matériaux Sabag printing concrete elements
Basel Area Business & Innovation, Innovation, Invest

Matériaux Sabag printing concrete elements

The Jura-based company Matériaux Sabag is now using a 3D printing solution to produce its concrete elements. This approach allows...

Read More
Six companies win the i4Challenge
Basel Area Business & Innovation, Innovation

Six companies win the i4Challenge

The i4Challenge expert jury has selected six winners from 18 finalists. The Industry 4.0 solutions range from 3D printing, IoT,...

Read More
Monte Rosa Therapeutics banks 96 million US dollars
Basel Area Business & Innovation, Innovation, Invest

Monte Rosa Therapeutics banks 96 million US dollars

The Basel-based biotechnology firm Monte Rosa Therapeutics has raised a total of 96 million US dollars after closing a successful...

Read More
Roche launches new coronavirus antibody test
Basel Area Business & Innovation, Innovation, Invest

Roche launches new coronavirus antibody test

Roche is launching on the market a new antibody test to determine coronavirus infections. This should help with the development...

Read More
Investors see great potential in Polyneuron
Basel Area Business & Innovation, Innovation, Invest

Investors see great potential in Polyneuron

The Basel-based company Polyneuron Pharmaceuticals extended its Series A funding round and has now raised a total of 36.5 million...

Read More
Lonza set to manufacture coronavirus drug for Humanigen
Basel Area Business & Innovation, Innovation, Invest

Lonza set to manufacture coronavirus drug for Humanigen

The Basel-based pharmaceutical supplier Lonza is supporting the US firm Humanigen in the development of a potential coronavirus therapeutic. Lonza...

Read More
1 2 3 21

Do you have a question? We'd like to hear from you.